Tag Archives: CBD

Marijuana is Connected to Psychosis and Schizophrenia

11717A study from the University of Pittsburgh which denies the mental health hazards of marijuana is surprising, since there are many other scientific studies pointing to a causal or trigger relationship between marijuana use and psychosis potentially developing into schizophrenia. The Pittsburgh study is limited by its small size; reliance on self-reporting and lack of diversity.  In fact, the sample size of 408 was 55% African American and included virtually no Hispanics or Asians.  It began in 1987, when the THC in marijuana was lower.  Read Dr. Christine Miller’s article on Marijuana Myths.

Research in the UK[i] reveals than one in four serious mental disorders are a result of “skunk” (i.e. high THC pot) including Continue reading Marijuana is Connected to Psychosis and Schizophrenia

American Epilepsy Association Statement on CBD Oils

The following letter was written by Dr. Amy Brooks-Kayal to a state representative in Pennsylvania.  Here is an article where the letter had been published.

March 22, 2015

Dear Representative,

As Pennsylvania considers enacting new cannabis legislation (HB 193), I write to offer the perspective of the American Epilepsy Society (AES), the leading U.S. organization of clinical and research professionals specializing in the treatment and care of people with epilepsy. Continue reading American Epilepsy Association Statement on CBD Oils

Judge Upholds the Schedule I Classification

On Wednesday, April 15, 2015, Judge Kimberly J Mueller of the US Court in Sacramento upheld the constitutionality of marijuana’s Schedule I designation in the 5-tier classification set down by Congress in 1970.   Schedule I drugs must have a high potential for abuse.

On April 16, 2015, Governor Butch Otter of Idaho issued an executive order allowing for expanded access to Epidiolex, a pure, pharmacy version of cannabidiol (CBD). He vetoed a bill that would have allowed non-pharmacy grade CBD for the treatment of seizures.

Parents Opposed to Pot calls on the national media to clarify the distinction between cannabidiol (CBD) Continue reading Judge Upholds the Schedule I Classification

Governor of Idaho Allows CBD Trial Medicine

Boise_IdahoOn  April 16, 2015, Governor Butch Otter of Idaho issued an executive order authorizing the Department of Health and Welfare to implement an FDA-approved expanded access program for treatment-resistant epilepsy in children.

He vetoed a bill that would have allowed a non-pharmacy grade of cannabidiol oil (CBD) to be purchased through an uncontrolled system from questionable sources. Instead, the governor decided upon a plan allowing children with intractable epilepsy to access Epidiolex, a pure, pharmaceutical-grade of CBD, through an FDA-approved clinical trial. Continue reading Governor of Idaho Allows CBD Trial Medicine